Stay updated on Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.

Latest updates to the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.1 is listed, replacing v3.4.0, with no substantive study content changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded a Show glossary option and updated QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check48 days agoChange DetectedA new consolidated Locations section has been added with state listings (California, New York, Oregon, Pennsylvania, Utah, Wisconsin) and the previous separate state location headings have been removed. This improves visibility of where the study is conducted.SummaryDifference0.7%

- Check76 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. This is a minor maintenance update that does not change the study details.SummaryDifference0.1%

- Check84 days agoChange DetectedThe government funding/operating status notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.